Celldex Therapeutics (CLDX) EPS (Basic) (2010 - 2026)
Celldex Therapeutics (CLDX) posted quarterly EPS (Basic) of -$1.29 for Q1 2026, up 99.84% year-over-year from -$0.65 in Q1 2025, and up 21.8% quarter-over-quarter from -$1.65 in Q4 2025.
Celldex Therapeutics (CLDX) EPS (Basic) (2010 - 2026) Analysis & Trends
Celldex Therapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$1.29 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 99.84% year-over-year to -$1.29; the TTM figure through Mar 2026 stood at -$4.91 (up 99.82% YoY), while the FY2025 annual figure was -$9.96, up 99.59% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.29, up from -$1.65 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.49 in Q1 2022, with the low at -$1009.4 in Q3 2025.
- The 5-year median for EPS (Basic) is -$621.87 (2023), against an average of -$517.34.
- The sharpest annual moves came in 2023 and 2026: EPS (Basic) tumbled 141703.71% in 2023, then surged 99.84% in 2026.
- Celldex Therapeutics' EPS (Basic) stood at -$564.9 in 2022, then tumbled by 58.23% to -$893.85 in 2023, then rose by 18.12% to -$731.87 in 2024, then soared by 99.77% to -$1.65 in 2025, then grew by 21.8% to -$1.29 in 2026.
- Business Quant data shows CLDX's EPS (Basic) at -$1.29 in Q1 2026, -$1.65 in Q4 2025, and -$1009.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | -0.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.96 |
| Mar 31, 2026 | -1.29 |
| Dec 31, 2025 | -1.65 |
| Sep 30, 2025 | -1,009.44 |
| Jun 30, 2025 | -967.04 |
| Mar 31, 2025 | -810.39 |
| Dec 31, 2024 | -731.87 |
| Sep 30, 2024 | -635.37 |
| Jun 30, 2024 | -542.90 |
| Mar 31, 2024 | -557.29 |
| Dec 31, 2023 | -893.85 |
| Sep 30, 2023 | -809.55 |
| Jun 30, 2023 | -645.50 |
| Mar 31, 2023 | -621.87 |
| Dec 31, 2022 | -564.90 |
| Sep 30, 2022 | -0.57 |
| Jun 30, 2022 | -0.77 |
| Mar 31, 2022 | -0.49 |
| Dec 31, 2021 | -469.98 |
| Sep 30, 2021 | -0.45 |